SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-218682
Filing Date
2022-08-11
Accepted
2022-08-11 17:03:07
Documents
17
Period of Report
2022-08-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d261363d8k.htm   iXBRL 8-K 30250
2 EX-1.1 d261363dex11.htm EX-1.1 183256
3 EX-5.1 d261363dex51.htm EX-5.1 6891
4 EX-99.1 d261363dex991.htm EX-99.1 7259
5 EX-99.2 d261363dex992.htm EX-99.2 7331
9 GRAPHIC g261363dsp50.jpg GRAPHIC 9060
  Complete submission text file 0001193125-22-218682.txt   429786

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA krtx-20220808.xsd EX-101.SCH 2849
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE krtx-20220808_lab.xml EX-101.LAB 17996
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krtx-20220808_pre.xml EX-101.PRE 11257
11 EXTRACTED XBRL INSTANCE DOCUMENT d261363d8k_htm.xml XML 3335
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38958 | Film No.: 221156812
SIC: 2834 Pharmaceutical Preparations